Abingdon Health enters into a partnership with Sumitomo Chemical to build on the rapid diagnostic test platform developed by Sumitomo and Abingdon Health subsidiary Molecular Vision.

Oxford spinout Zegami aims for a $10m funding round to commercialise its data discovery platform.

Oxford Sciences Innovation takes part in Oxstem's $24.4m round as it begins to develop pre-clinical small molecule drug candidates for its stem cell drugs.

A universal flu vaccine developed by Oxford spinout Vaccitech shows promising results in trials as the firm launches with a $14.5m seed round.

The media company, which already held a 22% stake in fashion platform Stylight, has agreed to buy the remaining 78%, giving an exit to Tengelmann Ventures and Holtzbrinck Ventures.

Volkswagen has become the latest carmaker to invest in on-demand mobility, providing $300m for ride hailing technology provider Gett.

IP Group has invested in Consequential Robotics as the company is spun out of Sheffield University.

David Newlands is set to replace current non-executive chairman Martin Knight in August 2016.